Founders Financial Securities LLC Biogen Inc. Transaction History

Founders Financial Securities LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $200,073 - $260,918	-707 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $183,113 - $293,199	707 New	707 $245,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $329,274 - $436,066	-1,273 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $5,914 - $7,502	22 Added 1.76%	1,273 $403,000
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $275,295 - $380,391	1,251 New	1,251 $371,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Founders Financial Securities LLC with notifications on news.